Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

In-silico identification of the vaccine candidate epitopes against the Lassa virus hemorrhagic fever.

Scientific reports - 6 May 2020

Baral Prabin, Pavadai Elumalai, Gerstman Bernard S, Chapagain Prem P

Abstract excerpt

Lassa virus (LASV), a member of the Arenaviridae, is an ambisense RNA virus that causes severe hemorrhagic fever with a high fatality rate in humans in West and Central Africa. Currently, no FDA approved drugs or vaccines are available for the treatment of LASV fever. The LASV glycoprotein complex (GP) is a promising target for vaccine or drug development. It is situated on the virion envelope and plays key roles...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Epitope Mapping
Share to Epitopes
Share to Epitopes, B-Lymphocyte

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Epitopes, T-Lymphocyte

Share to Histocompatibility Antigens Class I

Share to Viral Proteins

Share to Viral Vaccines

Share to Workflow

Source

Open in PubMed Open full text

Identifiers

PMID: 32376973
DOI: 10.1038/s41598-020-63640-1
PMCID: PMC7203123

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

In-silico identification of the vaccine candidate epitopes against the Lassa virus hemorrhagic fever.PMID 32376973Read ↗

A Mutation-Based Reverse Vaccinology Approach Considering Variability in Epitopes to Combat Multi-Strains: A Study Using Glycoprotein of LASV.Semantic proximity Read ↗

Design and In Silico Validation of a Novel Multi-Epitopes Subunit Vaccine Candidate against Lassa Virus Using Reverse Vaccinology ApproachSemantic proximity Read ↗

Designing a multi-epitope vaccine against the Lassa virus through reverse vaccinology, subtractive proteomics, and immunoinformatics approachesSemantic proximity Read ↗

Conglomeration of highly antigenic nucleoproteins to inaugurate a heterosubtypic next generation vaccine candidate against Arenaviridae familySemantic proximity Read ↗

Immunoinformatic screening of Marburgvirus epitopes and computational investigations of epitope-allele complexes.Semantic proximity Read ↗

Identification of Protective Lassa Virus Epitopes That Are Restricted by HLA-A2Semantic proximity Read ↗

Conformational ensemble-based framework enables rapid development of Lassa virus vaccine candidatesSemantic proximity Read ↗

Epitope - based peptide vaccine against glycoprotein GPC precursor of <i>Lujo virus</i> using immunoinformatics approachesSemantic proximity Read ↗

Design of an Epitope-Based Vaccine Ensemble for Animal Trypanosomiasis by Computational MethodsSemantic proximity Read ↗

Design of a new multi-epitope subunit vaccine to combat the EIA virus, targeting Pol, Gag, and Env proteins: In silico techniqueSemantic proximity Read ↗

Vaccines inducing immunity to Lassa virus glycoprotein and nucleoprotein protect macaques after a single shotSemantic proximity Read ↗

In Silico Development of a Multi-Epitope Subunit Vaccine against Bluetongue Virus in Ovis aries Using ImmunoinformaticsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.